Activity Provided By:

ACHL

COVID-19 and Rheumatology Care: How Does it Impact My Patients?

Overview / Abstract:	Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field that provide the dimension and context needed to interpret the latest data and guidance. This CME-certified session tackles the tough questions surrounding COVID-19 and rheumatology care with discussion on: • Impact of immunomodulatory therapies on COVID-19 infection risk • Vaccine considerations • Telemedicine • Long-hauler symptoms post-acute COVID-19 illness CME/CPE credit available!
Expiration	Apr 06, 2022
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Respiratory Therapy CE
Format	Webinar / Webcast / Video
Credits / Hours	.75
Accreditation	ACCME and ACPE
Presenters / Authors / Faculty	Allan Gibofsky, MD, JD, MACR, FACP, FCLM Professor of Medicine, Healthcare Policy and Research Weill Medical College of Cornell University Attending Rheumatologist Hospital for Special Surgery New York, NY Jonathan Jones, MD Rheumatologist Samaritan Rheumatology Corvallis, OR
Activity Specialities / Related Topics	Family Medicine, Immunizations / Vaccinations, Immunology / Immunosuppression, Internal Medicine, Primary Care, Rheumatology / Arthritis, Telemedicine / Telepharmacy
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Cardinal Health.
Keywords / Search Terms	ACHL Cardinal Health,COVID-19, Rheumatoid Arthritis, RA, RA Guidelines, inflammation, rheumatologist, internist, pain management, inflammatory disease, autoimmune disorders, immune-mediated inflammatory diseases, cytokine-mediated inflammatory diseases, chronic inflammation, novel rheumatology drugs, tofacitinib, baricitinib, filgotinib, upadacitinib, Immunomodulatory treatment, ACR guidelines, IIL-6 inhibitors, telemedicine Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map